GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Consensus Recommendation of “Moderate Buy” by Brokerages

by · The Markets Daily

GE HealthCare Technologies Inc. (NASDAQ:GEHC – Get Free Report) has been given an average rating of “Moderate Buy” by the eleven brokerages that are presently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $88.40.

Several equities analysts recently issued reports on GEHC shares. BTIG Research restated a “buy” rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Citigroup boosted their price target on GE HealthCare Technologies from $89.00 to $93.00 and gave the company a “buy” rating in a research note on Thursday, July 31st. Zacks Research upgraded GE HealthCare Technologies from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 28th. Morgan Stanley lowered their price target on GE HealthCare Technologies from $78.00 to $74.00 and set an “equal weight” rating on the stock in a research note on Thursday, July 31st. Finally, Wall Street Zen upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, May 31st.

Check Out Our Latest Report on GE HealthCare Technologies

Institutional Investors Weigh In On GE HealthCare Technologies

Several large investors have recently modified their holdings of the stock. Vanguard Group Inc. grew its stake in shares of GE HealthCare Technologies by 1.4% in the 2nd quarter. Vanguard Group Inc. now owns 52,107,758 shares of the company’s stock valued at $3,859,622,000 after purchasing an additional 703,903 shares during the period. Dodge & Cox grew its stake in shares of GE HealthCare Technologies by 42.1% in the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock valued at $1,745,678,000 after purchasing an additional 6,982,441 shares during the period. State Street Corp grew its stake in shares of GE HealthCare Technologies by 1.9% in the 2nd quarter. State Street Corp now owns 19,660,742 shares of the company’s stock valued at $1,456,271,000 after purchasing an additional 372,755 shares during the period. Geode Capital Management LLC grew its stake in shares of GE HealthCare Technologies by 2.0% in the 2nd quarter. Geode Capital Management LLC now owns 11,944,407 shares of the company’s stock valued at $881,060,000 after purchasing an additional 231,302 shares during the period. Finally, Norges Bank bought a new stake in shares of GE HealthCare Technologies in the 2nd quarter valued at approximately $468,120,000. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Trading Down 0.4%

GE HealthCare Technologies stock opened at $77.48 on Wednesday. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16. The business’s 50-day simple moving average is $74.56 and its 200-day simple moving average is $73.39. The firm has a market capitalization of $35.37 billion, a PE ratio of 15.88, a PEG ratio of 2.97 and a beta of 1.13. GE HealthCare Technologies has a 52 week low of $57.65 and a 52 week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.15. The business had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The firm’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.00 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Equities research analysts forecast that GE HealthCare Technologies will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 25th were paid a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date was Friday, July 25th. GE HealthCare Technologies’s dividend payout ratio is currently 2.87%.

About GE HealthCare Technologies

(Get Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

See Also